Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.35)
# 1,335
Out of 5,096 analysts
332
Total ratings
41.1%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Reiterated: Buy | $100 | $27.28 | +266.57% | 36 | Oct 28, 2026 | |
| VCRE Vicore Pharma Holding AB | Reiterated: Buy | $35 | $9.80 | +257.14% | 1 | Oct 22, 2026 | |
| EYPT EyePoint | Reiterated: Hold | n/a | $0.3484 | - | 4 | Oct 19, 2026 | |
| LXRX Lexicon Pharmaceuticals | Reiterated: Buy | $8 | $1.42 | +463.38% | 2 | Oct 18, 2026 | |
| ARQT Arcutis Biotherapeutics | Initiated Coverage: Buy | $48 | $32.07 | +49.67% | 1 | Oct 15, 2026 | |
| SRZN Surrozen | Reiterated: Buy | $40 | $29.04 | +37.74% | 4 | Oct 11, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $7 | $3.96 | +76.77% | 9 | Sep 28, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $15 | $3.67 | +308.72% | 6 | Sep 10, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $46 → $65 | $33.53 | +93.86% | 7 | Sep 9, 2026 | |
| INVA Innoviva | Reiterated: Buy | $34 | $21.22 | +60.23% | 7 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $266 → $270 | $154.74 | +74.49% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.37 | +629.93% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.39 | +475.54% | 12 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $28.24 | +211.61% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $29.82 | +47.55% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.80 | +316.67% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $6 | $1.66 | +261.45% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $14.32 | +53.68% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $12 | $12.27 | -2.20% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $29 | $8.47 | +242.38% | 4 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 33.00 | kr 9.88 | +234.01% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $13 | $3.59 | +262.12% | 9 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7928 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | ¥261 | +332.95% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $20.06 | +144.27% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $165.00 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $8.91 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $103 | $170.68 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.67 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $17 | $4.04 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $51 | $82.38 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $56 | $16.69 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $77 | $85.00 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $17 | $2.98 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $78 | $12.47 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $35 | $2.44 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $126.63 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $430.36 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $5 | $10.38 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $48.28 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $11.03 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.56 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $253.62 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $51.42 | n/a | 12 | Jun 13, 2021 |
Viking Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $100
Current: $27.28
Upside: +266.57%
Vicore Pharma Holding AB
Oct 22, 2026
Reiterated: Buy
Price Target: $35
Current: $9.80
Upside: +257.14%
EyePoint
Oct 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3484
Upside: -
Lexicon Pharmaceuticals
Oct 18, 2026
Reiterated: Buy
Price Target: $8
Current: $1.42
Upside: +463.38%
Arcutis Biotherapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $48
Current: $32.07
Upside: +49.67%
Surrozen
Oct 11, 2026
Reiterated: Buy
Price Target: $40
Current: $29.04
Upside: +37.74%
Camp4 Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $7
Current: $3.96
Upside: +76.77%
Opus Genetics
Sep 10, 2026
Reiterated: Buy
Price Target: $15
Current: $3.67
Upside: +308.72%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $46 → $65
Current: $33.53
Upside: +93.86%
Innoviva
Aug 20, 2026
Reiterated: Buy
Price Target: $34
Current: $21.22
Upside: +60.23%
Aug 14, 2026
Reiterated: Buy
Price Target: $266 → $270
Current: $154.74
Upside: +74.49%
Aug 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
Aug 14, 2026
Reiterated: Buy
Price Target: $8
Current: $1.39
Upside: +475.54%
Aug 10, 2026
Reiterated: Buy
Price Target: $88
Current: $28.24
Upside: +211.61%
Aug 10, 2026
Reiterated: Buy
Price Target: $44
Current: $29.82
Upside: +47.55%
Aug 6, 2026
Reiterated: Buy
Price Target: $20
Current: $4.80
Upside: +316.67%
Aug 6, 2026
Reiterated: Buy
Price Target: $4 → $6
Current: $1.66
Upside: +261.45%
Aug 6, 2026
Reiterated: Buy
Price Target: $22
Current: $14.32
Upside: +53.68%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $12.27
Upside: -2.20%
Jun 30, 2026
Reiterated: Buy
Price Target: $26 → $29
Current: $8.47
Upside: +242.38%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: kr 9.88
Upside: +234.01%
May 18, 2026
Reiterated: Buy
Price Target: $34 → $13
Current: $3.59
Upside: +262.12%
Apr 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.7928
Upside: -
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: ¥261
Upside: +332.95%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $20.06
Upside: +144.27%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $165.00
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $22
Current: $8.91
Upside: n/a
Nov 8, 2024
Reiterated: Buy
Price Target: $93 → $103
Current: $170.68
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.67
Upside: n/a
May 10, 2024
Reiterated: Buy
Price Target: $22 → $17
Current: $4.04
Upside: n/a
Apr 18, 2024
Reiterated: Buy
Price Target: $24 → $51
Current: $82.38
Upside: n/a
Jan 3, 2024
Reiterated: Buy
Price Target: $27 → $56
Current: $16.69
Upside: n/a
Oct 18, 2023
Reiterated: Buy
Price Target: $84 → $77
Current: $85.00
Upside: n/a
Jun 23, 2023
Reiterated: Buy
Price Target: $25 → $17
Current: $2.98
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $94 → $78
Current: $12.47
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $33 → $35
Current: $2.44
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $126.63
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $430.36
Upside: n/a
Dec 7, 2022
Reiterated: Buy
Price Target: $15 → $5
Current: $10.38
Upside: n/a
Nov 9, 2022
Reiterated: Buy
Price Target: $38
Current: $48.28
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $11.03
Upside: n/a
Aug 6, 2021
Reiterated: Buy
Price Target: $18
Current: $4.56
Upside: n/a
Jul 22, 2021
Reiterated: Hold
Price Target: n/a
Current: $253.62
Upside: n/a
Jun 13, 2021
Reiterated: Sell
Price Target: n/a
Current: $51.42
Upside: n/a